TY  - JOUR
TT  - Effect of meloxicam on serum vitamin and cytokine levels during endotoxemia
AU  - Yurt, Akile Ozlem
PY  - 2012
DA  - March
JF  - Eurasian Journal of Veterinary Sciences
JO  - Eurasian J Vet Sci
PB  - Selcuk University
WT  - DergiPark
SN  - 1309-6958
SP  - 47
EP  - 53
VL  - 28
IS  - 1
KW  - Meloksikam
KW  - endotoksemi
KW  - vitamin
KW  - sitokin
N2  - Aim: The aim of this study is to evaluate the effects of meloxicam on serum vitamin and cytokine levels during lipopolysaccharide-induced endotoxemia. Serum biochemical concentrations were also evaluated. Materials and Methods: Fifty male adult Sprague Dawley rats were used in this research. Five rats were reserved to obtain 0 time data then the rest were divided into 3 equal groups. First group received lipopolysaccharide (4 mg, intraperitoneal), second group received meloxicam (50 mg/kg, intraperitoneal) and third group received lipopolysaccharide (4 mg, intraperitoneal) plus meloxicam (50 mg/kg, intraperitoneal). Blood samples were collected at 2, 4 and 8 hours after administrations. Serum retinol, β-carotene, vitamin C, interleukin-1α, interleukin-1β, interleukin-2 and routine biochemical values were measured. Results: After lipopolysaccharide administration, decreased β-carotene level (p<0.05) was inhibited by meloxicam while increased interleukin-1α level (p<0.05) could not. Lipopolysaccharide caused increase in damage indicator levels of heart, liver, kidney besides cholesterol and triglyceride (p<0.05) while meloxicam administration was inhibited increase in creatine kinase-MB and cholesterol levels but caused more increase in urea and triglyceride levels. Conclusion: Meloxicam may be useful in inhibiting vitamin loses and heart damage. In addition, non-steroidal anti-inflammatory drug and vitamin supplementation may be useful during acute phase of endotoxemia.
UR  - https://dergipark.org.tr/en/pub/eurasianjvetsci/issue//263772
L1  - https://dergipark.org.tr/en/download/article-file/230297
ER  -